Gluten-Free Diet in Celiac Disease-Forever and for All?

Alice Itzlinger, Federica Branchi, Luca Elli, Michael Schumann, Alice Itzlinger, Federica Branchi, Luca Elli, Michael Schumann

Abstract

The gluten-free diet is the only effective treatment available for celiac disease. However, it is difficult to adhere to and a closer look on the diet's implementation and indications reveals several ambiguities: Not only is there controversy on the threshold of gluten that can be tolerated in the frame of a strict gluten-free diet, but it is also unclear whether the gluten-free diet is an appropriate treatment in patient subgroups with asymptomatic or potential celiac disease. Reports from a number of research groups suggest that a certain proportion of patients may effectively develop tolerance to gluten and thus become suitable for gluten reintroduction over time. In this review, we set out to create an overview about the current state of research as regards the definition of a strict gluten-free diet in terms of the gluten thresholds considered tolerable and the indication for a gluten-free diet in the absence of histological abnormalities or symptoms. Furthermore, we discuss the concept that a gluten-free diet must be followed for life by all patients.

Keywords: adherence; gluten; mucosal recovery; serology; threshold; villous atrophy.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Rational approach to patients with potential CD.

References

    1. Ludvigsson J.F., Leffler D.A., Bai J.C., Biagi F., Fasano A., Green P.H.R., Hadjivassiliou M., Kaukinen K., Kelly C.P., Leonard J.N., et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52. doi: 10.1136/gutjnl-2011-301346.
    1. Ludvigsson J.F., Bai J.C., Biagi F., Card T.R., Ciacci C., Ciclitira P.J., Green P.H.R., Hadjivassiliou M., Holdoway A., van Heel D.A., et al. Diagnosis and management of adult coeliac disease: Guidelines from the British Society of Gastroenterology. Gut. 2014 doi: 10.1136/gutjnl-2013-306578.
    1. Husby S., Koletzko S., Korponay-Szabó I.R., Mearin M.L., Phillips A., Shamir R., Troncone R., Giersiepen K., Branski D., Catassi C., et al. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2012;54:136–160. doi: 10.1097/MPG.0b013e31821a23d0.
    1. Ciccocioppo R., Kruzliak P., Cangemi G.C., Pohanka M., Betti E., Lauret E., Rodrigo L. The Spectrum of Differences between Childhood and Adulthood Celiac Disease. Nutrients. 2015;7:8733–8751. doi: 10.3390/nu7105426.
    1. Barratt S.M., Leeds J.S., Sanders D.S. Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J. Gastrointest. Liver Dis. 2011;20:241–245.
    1. Ukkola A., Mäki M., Kurppa K., Collin P., Huhtala H., Kekkonen L., Kaukinen K. Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2011;9:118–123. doi: 10.1016/j.cgh.2010.10.011.
    1. Rubio-Tapia A., Rahim M.W., See J.A., Lahr B.D., Wu T.-T., Murray J.A. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am. J. Gastroenterol. 2010;105:1412–1420. doi: 10.1038/ajg.2010.10.
    1. Norsa L., Branchi F., Bravo M., Ferretti F., Roncoroni L., Somalvico F., Conte D., Bardella M.T., Fabiano S., Barigelletti G., et al. Celiac Disease 30 Years After Diagnosis: Struggling With Gluten-free Adherence or Gaining Gluten Tolerance? J. Pediatr. Gastroenterol. Nutr. 2018;67:361–366. doi: 10.1097/MPG.0000000000001995.
    1. Catassi C., Fabiani E., Iacono G., D’Agate C., Francavilla R., Biagi F., Volta U., Accomando S., Picarelli A., De Vitis I., et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am. J. Clin. Nutr. 2007;85:160–166. doi: 10.1093/ajcn/85.1.160.
    1. Collin P., Thorell L., Kaukinen K., Mäki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment. Pharmacol. Ther. 2004;19:1277–1283. doi: 10.1111/j.1365-2036.2004.01961.x.
    1. Hischenhuber C., Crevel R., Jarry B., Mäki M., Moneret-Vautrin D.A., Romano A., Troncone R., Ward R. Review article: Safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment. Pharmacol. Ther. 2006;23:559–575. doi: 10.1111/j.1365-2036.2006.02768.x.
    1. Gibert A., Espadaler M., Angel Canela M., Sánchez A., Vaqué C., Rafecas M. Consumption of gluten-free products: Should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.? Eur. J. Gastroenterol. Hepatol. 2006;18:1187–1195. doi: 10.1097/01.meg.0000236884.21343.e4.
    1. Commission Implementing Regulation (EU) No 828/2014 of 30 July 2014 on the Requirements for the Provision of Information to Consumers on the Absence or Reduced Presence of Gluten in Food Text with EEA Relevance. [(accessed on 16 October 2018)]; Available online: .
    1. Catassi C., Rossini M., Rätsch I.M., Bearzi I., Santinelli A., Castagnani R., Pisani E., Coppa G.V., Giorgi P.L. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: A clinical and jejunal morphometric study. Gut. 1993;34:1515–1519. doi: 10.1136/gut.34.11.1515.
    1. Ciclitira P.J., Evans D.J., Fagg N.L., Lennox E.S., Dowling R.H. Clinical testing of gliadin fractions in coeliac patients. Clin. Sci. 1984;66:357–364. doi: 10.1042/cs0660357.
    1. Collin P., Mäki M., Kaukinen K. Safe gluten threshold for patients with celiac disease: Some patients are more tolerant than others. Am. J. Clin. Nutr. 2007;86:260. doi: 10.1093/ajcn/86.1.260.
    1. Akobeng A.K., Thomas A.G. Systematic review: Tolerable amount of gluten for people with coeliac disease. Aliment. Pharmacol. Ther. 2008;27:1044–1052. doi: 10.1111/j.1365-2036.2008.03669.x.
    1. Peräaho M., Kaukinen K., Paasikivi K., Sievänen H., Lohiniemi S., Mäki M., Collin P. Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: Prospective and randomized study. Aliment. Pharmacol. Ther. 2003;17:587–594. doi: 10.1046/j.1365-2036.2003.01425.x.
    1. Lohiniemi S., Mäki M., Kaukinen K., Laippala P., Collin P. Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets. Scand. J. Gastroenterol. 2000;35:947–949.
    1. Selby W.S., Painter D., Collins A., Faulkner-Hogg K.B., Loblay R.H. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand. J. Gastroenterol. 1999;34:909–914.
    1. Ciacci C., Cirillo M., Cavallaro R., Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: Prevalence and correlates of intestinal damage. Digestion. 2002;66:178–185. doi: 10.1159/000066757.
    1. Mahadev S., Murray J.A., Wu T.-T., Chandan V.S., Torbenson M.S., Kelly C.P., Maki M., Green P.H.R., Adelman D., Lebwohl B. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment. Pharmacol. Ther. 2017;45:1084–1093. doi: 10.1111/apt.13988.
    1. Biagi F., Andrealli A., Bianchi P.I., Marchese A., Klersy C., Corazza G.R. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br. J. Nutr. 2009;102:882–887. doi: 10.1017/S0007114509301579.
    1. De Lourdes Moreno M., Cebolla Á., Muñoz-Suano A., Carrillo-Carrion C., Comino I., Pizarro Á., León F., Rodríguez-Herrera A., Sousa C. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. 2017;66:250–257. doi: 10.1136/gutjnl-2015-310148.
    1. Moreno Amador M.L., Rodríguez-Herrera A., Sousa C., Comino I. Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients. Nutrients. 2017;9 doi: 10.3390/nu9010046.
    1. Comino I., Fernández-Bañares F., Esteve M., Ortigosa L., Castillejo G., Fambuena B., Ribes-Koninckx C., Sierra C., Rodríguez-Herrera A., Salazar J.C., et al. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients. Am. J. Gastroenterol. 2016;111:1456–1465. doi: 10.1038/ajg.2016.439.
    1. Leonard M.M., Cureton P., Fasano A. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease. Nutrients. 2017;9 doi: 10.3390/nu9101129.
    1. Hollon J.R., Cureton P.A., Martin M.L., Puppa E.L.L., Fasano A. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol. 2013;13:40. doi: 10.1186/1471-230X-13-40.
    1. Zanini B., Marullo M., Villanacci V., Salemme M., Lanzarotto F., Ricci C., Lanzini A. Persistent Intraepithelial Lymphocytosis in Celiac Patients Adhering to Gluten-Free Diet Is Not Abolished Despite a Gluten Contamination Elimination Diet. Nutrients. 2016;8 doi: 10.3390/nu8090525.
    1. Elfström P., Sundström J., Ludvigsson J.F. Systematic review with meta-analysis: Associations between coeliac disease and type 1 diabetes. Aliment. Pharmacol. Ther. 2014;40:1123–1132. doi: 10.1111/apt.12973.
    1. Viljamaa M., Kaukinen K., Huhtala H., Kyrönpalo S., Rasmussen M., Collin P. Coeliac disease, autoimmune diseases and gluten exposure. Scand. J. Gastroenterol. 2005;40:437–443. doi: 10.1080/00365520510012181.
    1. Hadithi M., de Boer H., Meijer J.W.R., Willekens F., Kerckhaert J.A., Heijmans R., Peña A.S., Stehouwer C.D.A., Mulder C.J.J. Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J. Gastroenterol. 2007;13:1715–1722. doi: 10.3748/wjg.v13.i11.1715.
    1. Diamanti A., Capriati T., Bizzarri C., Ferretti F., Ancinelli M., Romano F., Perilli A., Laureti F., Locatelli M. Autoimmune diseases and celiac disease which came first: Genotype or gluten? Expert Rev. Clin. Immunol. 2016;12:67–77. doi: 10.1586/1744666X.2016.1095091.
    1. Ventura A., Magazzù G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology. 1999;117:297–303. doi: 10.1053/gast.1999.0029900297.
    1. Sategna Guidetti C., Solerio E., Scaglione N., Aimo G., Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut. 2001;49:502–505. doi: 10.1136/gut.49.4.502.
    1. Metso S., Hyytiä-Ilmonen H., Kaukinen K., Huhtala H., Jaatinen P., Salmi J., Taurio J., Collin P. Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study. Scand. J. Gastroenterol. 2012;47:43–48. doi: 10.3109/00365521.2011.639084.
    1. Mustalahti K., Collin P., Sievänen H., Salmi J., Mäki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet Lond. Engl. 1999;354:744–745. doi: 10.1016/S0140-6736(99)01990-X.
    1. Majorana A., Bardellini E., Ravelli A., Plebani A., Polimeni A., Campus G. Implications of gluten exposure period, CD clinical forms, and HLA typing in the association between celiac disease and dental enamel defects in children. A case-control study. Int. J. Paediatr. Dent. 2010;20:119–124. doi: 10.1111/j.1365-263X.2009.01028.x.
    1. Fuchs V., Kurppa K., Huhtala H., Mäki M., Kekkonen L., Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: A prospective nationwide study. United Eur. Gastroenterol. J. 2018;6:567–575. doi: 10.1177/2050640617751253.
    1. Pantaleoni S., Luchino M., Adriani A., Pellicano R., Stradella D., Ribaldone D.G., Sapone N., Isaia G.C., Di Stefano M., Astegiano M. Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet. Sci. World J. 2014;2014:173082. doi: 10.1155/2014/173082.
    1. Laurikka P., Salmi T., Collin P., Huhtala H., Mäki M., Kaukinen K., Kurppa K. Gastrointestinal Symptoms in Celiac Disease Patients on a Long-Term Gluten-Free Diet. Nutrients. 2016;8 doi: 10.3390/nu8070429.
    1. Rubio-Tapia A., Kyle R.A., Kaplan E.L., Johnson D.R., Page W., Erdtmann F., Brantner T.L., Kim W.R., Phelps T.K., Lahr B.D., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93. doi: 10.1053/j.gastro.2009.03.059.
    1. Metzger M.-H., Heier M., Mäki M., Bravi E., Schneider A., Löwel H., Illig T., Schuppan D., Wichmann H.-E. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: The KORA/MONICA Augsburg cohort study 1989-1998. Eur. J. Epidemiol. 2006;21:359–365. doi: 10.1007/s10654-006-9002-4.
    1. Catassi C., Fabiani E., Corrao G., Barbato M., De Renzo A., Carella A.M., Gabrielli A., Leoni P., Carroccio A., Baldassarre M., et al. Italian Working Group on Coeliac Disease and Non-Hodgkin’s-Lymphoma Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 2002;287:1413–1419. doi: 10.1001/jama.287.11.1413.
    1. Logan R.F., Rifkind E.A., Turner I.D., Ferguson A. Mortality in celiac disease. Gastroenterology. 1989;97:265–271. doi: 10.1016/0016-5085(89)90060-7.
    1. West J., Logan R.F.A., Smith C.J., Hubbard R.B., Card T.R. Malignancy and mortality in people with coeliac disease: Population based cohort study. BMJ. 2004;329:716–719. doi: 10.1136/bmj.38169.486701.7C.
    1. Chander U., Leeman-Neill R.J., Bhagat G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Curr. Hematol. Malig. Rep. 2018;13:308–317. doi: 10.1007/s11899-018-0459-5.
    1. Lohi S., Mäki M., Rissanen H., Knekt P., Reunanen A., Kaukinen K. Prognosis of unrecognized coeliac disease as regards mortality: A population-based cohort study. Ann. Med. 2009;41:508–515. doi: 10.1080/07853890903036199.
    1. Olén O., Askling J., Ludvigsson J.F., Hildebrand H., Ekbom A., Smedby K.E. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig. Liver Dis. 2011;43:862–868. doi: 10.1016/j.dld.2011.07.012.
    1. Biagi F., Corazza G.R. Mortality in celiac disease. Nat. Rev. Gastroenterol. Hepatol. 2010;7:158–162. doi: 10.1038/nrgastro.2010.2.
    1. Kurppa K., Paavola A., Collin P., Sievänen H., Laurila K., Huhtala H., Saavalainen P., Mäki M., Kaukinen K. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. Gastroenterology. 2014;147:610–617. doi: 10.1053/j.gastro.2014.05.003.
    1. Volta U., Caio G., Giancola F., Rhoden K.J., Ruggeri E., Boschetti E., Stanghellini V., Giorgio R.D. Features and Progression of Potential Celiac Disease in Adults. Clin. Gastroenterol. Hepatol. 2016;14:686–693. doi: 10.1016/j.cgh.2015.10.024.
    1. Lebwohl B., Kapel R.C., Neugut A.I., Green P.H.R., Genta R.M. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest. Endosc. 2011;74:103–109. doi: 10.1016/j.gie.2011.03.1236.
    1. Gonzalez S., Gupta A., Cheng J., Tennyson C., Lewis S.K., Bhagat G., Green P.H.R. Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest. Endosc. 2010;72:758–765. doi: 10.1016/j.gie.2010.06.026.
    1. Villanacci V., Lorenzi L., Donato F., Auricchio R., Dziechciarz P., Gyimesi J., Koletzko S., Mišak Z., Laguna V.M., Polanco I., et al. Histopathological evaluation of duodenal biopsy in the PreventCD project. An observational interobserver agreement study. APMIS Acta Pathol. Microbiol. Immunol. Scand. 2018;126:208–214. doi: 10.1111/apm.12812.
    1. Corazza G.R., Villanacci V., Zambelli C., Milione M., Luinetti O., Vindigni C., Chioda C., Albarello L., Bartolini D., Donato F. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2007;5:838–843. doi: 10.1016/j.cgh.2007.03.019.
    1. Taavela J., Koskinen O., Huhtala H., Lähdeaho M.-L., Popp A., Laurila K., Collin P., Kaukinen K., Kurppa K., Mäki M. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS ONE. 2013;8:e76163. doi: 10.1371/journal.pone.0076163.
    1. Mandile R., Discepolo V., Scapaticci S., Del Vecchio M.R., Maglio M.A., Greco L., Troncone R., Auricchio R. The Effect of Gluten-free Diet on Clinical Symptoms and the Intestinal Mucosa of Patients With Potential Celiac Disease. J. Pediatr. Gastroenterol. Nutr. 2018;66:654–656. doi: 10.1097/MPG.0000000000001745.
    1. Biagi F., Trotta L., Alfano C., Balduzzi D., Staffieri V., Bianchi P.I., Marchese A., Vattiato C., Zilli A., Luinetti O., et al. Prevalence and natural history of potential celiac disease in adult patients. Scand. J. Gastroenterol. 2013;48:537–542. doi: 10.3109/00365521.2013.777470.
    1. Lionetti E., Castellaneta S., Pulvirenti A., Tonutti E., Francavilla R., Fasano A., Catassi C. Italian Working Group of Weaning and Celiac Disease Risk Prevalence and natural history of potential celiac disease in at-family-risk infants prospectively investigated from birth. J. Pediatr. 2012;161:908–914. doi: 10.1016/j.jpeds.2012.05.008.
    1. Auricchio R., Tosco A., Piccolo E., Galatola M., Izzo V., Maglio M., Paparo F., Troncone R., Greco L. Potential celiac children: 9-year follow-up on a gluten-containing diet. Am. J. Gastroenterol. 2014;109:913–921. doi: 10.1038/ajg.2014.77.
    1. Elli L., Discepolo V., Bardella M.T., Guandalini S. Does gluten intake influence the development of celiac disease-associated complications? J. Clin. Gastroenterol. 2014;48:13–20. doi: 10.1097/MCG.0b013e3182a9f898.
    1. Mäki M., Lähdeaho M.L., Hällström O., Viander M., Visakorpi J.K. Postpubertal gluten challenge in coeliac disease. Arch. Dis. Child. 1989;64:1604–1607. doi: 10.1136/adc.64.11.1604.
    1. Matysiak-Budnik T., Malamut G., de Serre N.P.-M., Grosdidier E., Seguier S., Brousse N., Caillat-Zucman S., Cerf-Bensussan N., Schmitz J., Cellier C. Long-term follow-up of 61 coeliac patients diagnosed in childhood: Evolution toward latency is possible on a normal diet. Gut. 2007;56:1379–1386. doi: 10.1136/gut.2006.100511.
    1. Hopman E.G.D., von Blomberg M.E., Batstra M.R., Morreau H., Dekker F.W., Koning F., Lamers C.B.H.W., Mearin M.L. Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur. J. Gastroenterol. Hepatol. 2008;20:423–429. doi: 10.1097/MEG.0b013e3282f4de6e.
    1. Kivelä L., Popp A., Arvola T., Huhtala H., Kaukinen K., Kurppa K. Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United Eur. Gastroenterol. J. 2018;6:1022–1031. doi: 10.1177/2050640618778386.
    1. O’Leary C., Wieneke P., Healy M., Cronin C., O’Regan P., Shanahan F. Celiac disease and the transition from childhood to adulthood: A 28-year follow-up. Am. J. Gastroenterol. 2004;99:2437–2441. doi: 10.1111/j.1572-0241.2004.40182.x.
    1. Wungjiranirun M., Kelly C.P., Leffler D.A. Current Status of Celiac Disease Drug Development. Am. J. Gastroenterol. 2016;111:779–786. doi: 10.1038/ajg.2016.105.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅